Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis

References

• Akena, D., Joska, J., Obuku, E. A., & Stein, D. J. (2013). Sensitivity and specificity of clinician administered screening instruments in detecting depression among HIV-positive individuals in Uganda. AIDS Care, 25(10), 1245–1252. doi: 10.1080/09540121.2013.764385
   PubMed Web of Science ®Google Scholar
• Akena, D., Musisi, S., Joska, J., & Stein, D. J. (2012). The association between AIDS related stigma and major depressive disorder among HIV-positive individuals in Uganda. PLoS One, 7(11), e48671. doi: 10.1371/journal.pone.0048671
   PubMed Web of Science ®Google Scholar
• Akena, D. H., Musisi, S., & Kinyanda, E. (2010). A comparison of the clinical features of depression in HIV-positive and HIV-negative patients in Uganda. Afr J Psychiatry (Johannesbg), 13(1), 43–51.
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., … Moss, a. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. Aids (london, England), 14(4), 357–366. doi: 10.1097/00002030-200003100-00008
   PubMed Web of Science ®Google Scholar
• Bendavid, E., Young, S. D., Katzenstein, D. A., Bayoumi, A. M., Sanders, G. D., & Owens, D. K. (2008). Cost-effectiveness of HIV monitoring strategies in resource-limited settings: A southern African analysis. Archives of Internal Medicine, 168(17), 1910–1918. doi: 10.1001/archinternmed.2008.1
   PubMedGoogle Scholar
• Bernard, C., Dabis, F., & de Rekeneire, N. (2017). Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One, 12(8), e0181960. doi: 10.1371/journal.pone.0181960
   PubMed Web of Science ®Google Scholar
• Breuer, E., Myer, L., Struthers, H., & Joska, J. A. (2011). HIV/AIDS and mental health research in sub-Saharan Africa: A systematic review. African Journal of Aids Research, 10(2), 101–122. doi: 10.2989/16085906.2011.593373
   PubMed Web of Science ®Google Scholar
• Byakika-Tusiime, J., Crane, J., Oyugi, J. H., Ragland, K., Kawuma, A., Musoke, P., & Bangsberg, D. R. (2009). Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus Family treatment model: Role of depression in declining adherence over time. AIDS and Behavior, 13(1), 82–91. doi: 10.1007/s10461-009-9546-x
   PubMed Web of Science ®Google Scholar
• Chibanda, D., Bowers, T., Verhey, R., Rusakaniko, S., Abas, M., Weiss, H. A., & Araya, R. (2015). The Friendship Bench programme: A cluster randomised controlled trial of a brief psychological intervention for common mental disorders delivered by lay health workers in Zimbabwe. International Journal of Mental Health Systems, 9, 21. doi: 10.1186/s13033-015-0013-y
   PubMed Web of Science ®Google Scholar
• Cholera, R., Pence, B. W., Gaynes, B. N., Bassett, J., Qangule, N., Pettifor, A., … Miller, W. C. (2017). Depression and engagement in care among newly diagnosed HIV-infected adults in Johannesburg, South Africa. AIDS and Behavior, 21(6), 1632–1640. doi: 10.1007/s10461-016-1442-6
   PubMed Web of Science ®Google Scholar
• Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158(5), 725–730. doi: 10.1176/appi.ajp.158.5.725
   PubMed Web of Science ®Google Scholar
• Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., … Xie, P. (2016). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. Lancet, 388(10047), 881–890. doi: 10.1016/S0140-6736(16)30385-3
   PubMed Web of Science ®Google Scholar
• Ferguson, N. M., Donnelly, C. A., Hooper, J., Ghani, A. C., Fraser, C., Bartley, L. M., … Anderson, R. M. (2005). Adherence to antiretroviral therapy and its impact on clinical outcomes in HIV-infected patients. Journal of the Royal Society, Interface, 2, 349–363. doi: 10.1098/rsif.2005.0037
   PubMed Web of Science ®Google Scholar
• Goldie, S. J., Yazdanpanah, Y., Losina, E., Weinstein, M. C., Anglaret, X., Walensky, R. P., … Freedberg, K. A. (2006). Cost-effectiveness of HIV treatment in resource-poor settings — the case of côte d'Ivoire. New England Journal of Medicine, 355(11), 1141–1153. doi: 10.1056/NEJMsa060247
   PubMed Web of Science ®Google Scholar
• Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58(2), 181–187. doi: 10.1097/QAI.0b013e31822d490a
   PubMed Web of Science ®Google Scholar
• Gupta, A. K., Dabla, V., Joshi, B. C., & Chakraborty, S. (2014). Challenges in retention of patients in continuum of HIV care in Delhi — experience of a decade & way ahead. World Journal of Aids, 4(4), 387–395. doi: 10.4236/wja.2014.44046
   Google Scholar
• Hollon, S. D., Stewart, M. O., & Strunk, D. (2006). Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annual Review of Psychology, 57, 285–315. doi: 10.1146/annurev.psych.57.102904.190044
   PubMed Web of Science ®Google Scholar
• Honagodu, A. R., Krishna, M., Sundarachar, R., & Lepping, P. (2013). Group psychotherapies for depression in persons with HIV: A systematic review. Indian Journal of Psychiatry, 55(4), 323–330. doi: 10.4103/0019-5545.120541
   PubMed Web of Science ®Google Scholar
• Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., … Kovach, D. a. (2008). Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 47(3), 384–390. doi: 10.1097/QAI.0b013e318160d53e
   PubMed Web of Science ®Google Scholar
• Hosseinipour, M. C., Bisson, G. P., Miyahara, S., Sun, X., Moses, A., Riviere, C., … Adult, A. C. T. G. A. S. T. (2016). Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet, 387(10024), 1198–1209. doi: 10.1016/S0140-6736(16)00546-8
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. (2017). Ending AIDS. Progress toward the 90-90-90 targets. Retrieved from http://www.unaids.org/sites/default/files/media_asset/Global_AIDS_update_2017_en.pdf
   Google Scholar
• Kaharuza, F. M., Bunnell, R., Moss, S., Purcell, D. W., Bikaako-Kajura, W., Wamai, N., … Mermin, J. (2006). Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS and Behavior, 10(1), 105–111. doi: 10.1007/s10461-006-9142-2
   PubMed Web of Science ®Google Scholar
• Kigozi, F., Ssebunnya, J., Kizza, D., Cooper, S., & Ndyanabangi, S. (2010). An overview of Uganda's mental health care system: Results from an assessment using the World health Organization's assessment instrument for mental health systems (WHO-AIMS). International Journal of Mental Health, 4(1), 1. doi: 10.1186/1752-4458-4-1
   Google Scholar
• Kinyanda, E., Hoskins, S., Nakku, J., Nawaz, S., & Patel, V. (2011). Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry, 11(1), 1. doi:10.1186/1471-244X-11-205 doi: 10.1186/1471-244X-11-1
   PubMedGoogle Scholar
• Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. doi: 10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Laxminarayan, R., Mills, A. J., Breman, J. G., Measham, A. R., Alleyne, G., Claeson, M., … Jamison, D. T. (2006). Advancement of global health: Key messages from the disease control Priorities Project. Lancet, 367(9517), 1193–1208. doi: 10.1016/S0140-6736(06)68440-7
   PubMed Web of Science ®Google Scholar
• McCreesh, N., Andrianakis, I., Nsubuga, R. N., Strong, M., Vernon, I., McKinley, T. J., … White, R. G. (2017). Universal test, treat, and keep: Improving ART retention is key in cost-effective HIV control in Uganda. BMC Infectious Diseases, 17(1), 322. doi: 10.1186/s12879-017-2420-y
   PubMedGoogle Scholar
• Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., … Bangsberg, D. R. (2006). Adherence to antiretroviral therapy in Sub-Saharan Africa and North America. JAMA, 296(6), 679–690. doi: 10.1001/jama.296.6.679
   PubMed Web of Science ®Google Scholar
• Murray, C. J., & Lopez, A. (2002). World health Report 2002: Reducing risks, promoting healthy life. Geneva. Retrieved from http://www.who.int/whr/2002/en/whr02_en.pdf
   Google Scholar
• Nakimuli-Mpungu, E., Wamala, K., Okello, J., Alderman, S., Odokonyero, R., Mojtabai, R., … Musisi, S. (2015). Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: A single-centre randomised controlled trial. The Lancet. Hiv, 2(5), e190–e199. doi: 10.1016/S2352-3018(15)00041-7
   PubMed Web of Science ®Google Scholar
• Ngo, V. K., Wagner, G. J., Nakasujja, N., Dickens, A., Aunon, F., & Musisi, S. (2014). Effectiveness of antidepressants and predictors of treatment response for depressed HIV patients in Uganda. International Journal of STD & AIDS, 26(14), 998–1006. doi: 10.1177/0956462414564606
   PubMed Web of Science ®Google Scholar
• Obirikorang, C., Selleh, P. K., Abledu, J. K., & Fofie, C. O. (2013). Predictors of adherence to antiretroviral therapy among HIV/AIDS patients in the upper west region of Ghana. ISRN AIDS, 2013. doi: 10.1155/2013/873939
   PubMedGoogle Scholar
• Ovuga, E., Boardman, J., & Wasserman, D. (2005). The prevalence of depression in two districts of Uganda. Social Psychiatry and Psychiatric Epidemiology, 40(6), 439–445. doi: 10.1007/s00127-005-0915-0
   PubMed Web of Science ®Google Scholar
• Patel, V., Chisholm, D., Rabe-Hesketh, S., Dias-Saxena, F., Andrew, G., & Mann, A. (2003). Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: A randomised, controlled trial. Lancet, 361(9351), 33–39. doi: 10.1016/S0140-6736(03)12119-8
   PubMed Web of Science ®Google Scholar
• Sanders, G. D., Neumann, P. J., Basu, A., et al. (2016). Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine. JAMA, 316(10), 1093–1103. doi: 10.1001/jama.2016.12195
   PubMed Web of Science ®Google Scholar
• Sin, N. L., & DiMatteo, M. R. (2014). Depression treatment enhances adherence to antiretroviral therapy: A meta-analysis. Annals of Behavioral Medicine, 47(3), 259–269. doi: 10.1007/s12160-013-9559-6
   PubMed Web of Science ®Google Scholar
• Spirig, R. (1998). Support groups for people living with HIV/AIDS: A review of literature. The Journal of the Association of Nurses in AIDS Care, 9(4), 43–55. doi: 10.1016/S1055-3290(98)80044-7
   PubMedGoogle Scholar
• Stegenga, B. T., Kamphuis, M. H., King, M., Nazareth, I., & Geerlings, M. I. (2012). The natural course and outcome of major depressive disorder in primary care: The PREDICT-NL study. Social Psychiatry and Psychiatric Epidemiology, 47(1), 87–95. doi: 10.1007/s00127-010-0317-9
   PubMed Web of Science ®Google Scholar
• Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M.-L. (2013). High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science, 339, 966–971. doi:10.1126/science.1228160.High doi: 10.1126/science.1228160
   PubMed Web of Science ®Google Scholar
• Wagner, G. J., Ghosh-Dastidar, B., Robinson, E., Ngo, V. K., Glick, P., Mukasa, B., … Akena, D. (2017). Effects of depression alleviation on ART adherence and HIV clinic attendance in Uganda, and the mediating roles of self-efficacy and motivation. AIDS and Behavior, 21(6), 1655–1664. doi: 10.1007/s10461-016-1500-0
   PubMed Web of Science ®Google Scholar
• Wagner, G. J., Ngo, V., Glick, P., Obuku, E. A., Musisi, S., & Akena, D. (2014). INtegration of DEPression treatment into HIV care in Uganda (INDEPTH-Uganda): study protocol for a randomized controlled trial. Trials, 15(1), 1. doi: 10.1186/1745-6215-15-248
   PubMedGoogle Scholar
• Weidle, P. J., Wamai, N., Solberg, P., Liechty, C., Sendagala, S., Were, W., … Bunnell, R. (2006). Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet, 368(9547), 1587–1594. doi: 10.1016/S0140-6736(06)69118-6
   PubMed Web of Science ®Google Scholar
• The World Bank. (2019). GDP per capita (current US$) - Sub-Saharan Africa. Retrieved from https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=ZG
   Google Scholar
• World Health Organization. (2001). Macroeconomics and health: Investing in health for economic development. Retrieved from http://www1.worldbank.org/publicsector/pe/PEAMMarch2005/CMHReport.pdf
   Google Scholar
• World Health Organization. (2009). Threshold values for intervention cost-effectiveness by region. Retrieved from http://www.who.int/choice/costs/CER_levels/en/index.html
   Google Scholar
• World Health Organization. (2014). International drug price indicator guide. Retrieved from http://apps.who.int/medicinedocs/en/m/abstract/Js21982en/
   Google Scholar